How copay accumulators and maximizers are shifting drug costs to patients and manufacturers
Recently, healthcare insurance companies and PBMs have been leveraging two new strategies that shift further costs onto commercially-covered
top of page
Request more information about RJW&partners
RJW&partners will only use your personal information to administer your account and provide the products and services you request. You can unsubscribe at any time, to do so please review our Privacy Policy. By clicking subscribe, you consent to allow RJW&partners to store and process your personal information.
bottom of page